Cargando…
Arterial hypertension management with conversion enzyme inhibitors in hemodialysis patients
By establishing the renal suppletion procedure, the patients with chronic renal failure also have an acceleration of arterial hypertension phenomena. The management of this situation calls for the understanding of the ethological mechanisms (hypervolemia by the reduction of Na excretion and high ren...
Autores principales: | Costea, AC, Costea, DO, David, C, Grasa, CN |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019039/ https://www.ncbi.nlm.nih.gov/pubmed/20302199 |
Ejemplares similares
-
Evolution of chronic hypertensive nephropathies treated with ACE
inhibitors on patients in pre-dialysis stage
por: Costea, Andreea-Cristina, et al.
Publicado: (2010) -
Serum levels of adipokines resistin and leptin in
patients with colon cancer
por: Sălăgeanu, A, et al.
Publicado: (2010) -
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
por: Tanase, Daniela Maria, et al.
Publicado: (2019) -
Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
por: Mateti, Uday Venkat, et al.
Publicado: (2014) -
Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study
por: Tumlin, James A., et al.
Publicado: (2019)